Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

0
Player Avatar darrylbrizan (94.63) Submitted: 5/29/2011 9:33:33 PM : Outperform Start Price: $41.16 GILD Score: +22.02

demographics

Report this Post Reply

Featured Broker Partners


Advertisement